Advancing Antibiotic Use and Preventing Hearing...

By HEOR Staff Writer

August 14, 2023

NICE has recommended further evidence generation for the Genedrive MT-RNR1 ID Kit, a technology developed to detect a genetic variant that guides antibiotic use and prevents hearing loss in babies. This plan outlines the gaps in evidence for th...
Unlocking the Value of Biosimilars: Challenges and Solutions
Exposing the Hidden Costs: Hospitals Charging 500% More for Medicines
Bridging the Gap Between Inpatient and Outpatient Care: A Shift in European H...
Closing the Global Health Gap: Progress Against HIV, TB, and Malaria
Unravelling the Mystery of Long COVID: HIQA Reviews Potential Interventions
Unleashing the Power of Cell and Gene Therapies: The Road to Market Access Su...
Antibiotics or Placebo? The Effectiveness & Cost of Treating Children wi...
EUnetHTA 21 Publication of Second Joint Clinical Assessment: Introducing the ...
Risk of Bleeding in Patients Undergoing Coronary Interventions on Dual and Tr...
New Hope for Sickle Cell Disease: Groundbreaking Gene Therapies Under Review
Unlocking the Economic Potential of Dementia Research: A Call for Increased I...
Breaking Down the Financial Burden of Health Expenses in India